Shefaa El Orman Oncology Hospital (SOH) in Luxor is a leading non-profit, charity hospital dedicated to providing free, high-quality cancer treatment to patients across Upper Egypt. Established through the collaboration of Shefaa Charity Foundation and Orman Charity Association, the hospital serves six governorates (Luxor, Sohag, Qena, Aswan, New Valley, Red Sea) with a combined population of 11 million. The hospital is equipped with state-of-the-art diagnostic and therapeutic technologies, and offers inpatient, outpatient, day care, radiology, nuclear medicine, clinical pharmacy, and laboratory services. SOH is also a center for cancer awareness, early detection, education, and research.

• Adult and pediatric oncology

• Chemotherapy and immunotherapy

• Radiation oncology

• Nuclear medicine

• Surgical oncology

• Mammography and breast MRI (including mobile mammography units)

• Genetic cancer risk assessment and research

• Multidisciplinary cancer care planning

• Palliative and supportive care

SOH is recognized for delivering clinical services of international quality free of charge. The hospital’s multidisciplinary team approach ensures each patient receives a personalized care plan. SOH is equipped with the latest diagnostic and treatment tools, comparable to leading international hospitals. The hospital is actively involved in early detection campaigns, annual screening programs, and genetic research for cancer prevention and control

Vision:
To be a pioneer in cancer care in Egypt by leading in education, training, development, innovation, and research to understand, treat, and prevent cancer.

Mission:
To provide the highest standard of specialized healthcare at no cost to all cancer patients in Upper Egypt, and to advance early detection and prevention to reduce cancer mortality and suffering.

• Full member of the Union for International Cancer Control (UICC).

• Recognized as the first and only comprehensive, free-of-charge cancer center serving Upper Egypt’s 11 million population.

• Known for large-scale cancer awareness and early detection campaigns, and for pioneering genetic research in the region.